Annals of African Medicine
Home About AAM Editorial board Ahead of print Current Issue Archives Instructions Subscribe Contact us Search Login 


 
Table of Contents
COMMENTARY
Year : 2012  |  Volume : 11  |  Issue : 2  |  Page : 121  

Chronic kidney disease in the developing countries! Are we really so different?


University Clinic of Nephrology, Medical Faculty Skopje, Vodnjanska 17, 1000 Skopje, Republic of Macedonia

Date of Web Publication6-Mar-2012

Correspondence Address:
Ninoslav Ivanovski
University Clinic of Nephrology, Medical Faculty Skopje, Vodnjanska 17, 1000 Skopje
Republic of Macedonia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Ivanovski N. Chronic kidney disease in the developing countries! Are we really so different?. Ann Afr Med 2012;11:121

How to cite this URL:
Ivanovski N. Chronic kidney disease in the developing countries! Are we really so different?. Ann Afr Med [serial online] 2012 [cited 2020 Oct 24];11:121. Available from: https://www.annalsafrmed.org/text.asp?2012/11/2/121/93538

The article "Chronic Kidney Disease in sub-Saharan Africa: Hypothesis for research demand" from Dr. Biruck published in this issue of the AAM put in the light many facts already very well known in the community of nephrologists all over the world. [1],[2],[3],[4] The everyday problems regarding the nephrological practice in the developing countries such as lack of certified nephrologists ("brain drain"), lack of sufficient facilities for treatment of end-stage renal disease (ESRD) like dialysis and transplantation, lack of useful registries of ESRD patients as well as regular screeing of the population are practically the same not only in sub-Saharan Africa and Asia, but also in certain region of South-Eastern Europe and Latin America. [5],[6] It is really very easy to follow the KDOQI guidelines in the developed world and discuss whether chronic kidney disease (CKD) stage 3 or 4 exists or not and where is a difference. But from the point of view of cruel reality, I could not find any sense when there are less than 20 prevalent ESRD patients who are on the regular dialysis treatment. [4] Especially when there is no precise information about CKD prevalence in different African countries as well the annual incidence of new ESRD patients. From that point of view, I fully agree with the demand of Dr. Biruck for research of the specificity of the CKD and ESRD in the Sub-Saharan region as long as some more basic information would be available. Therefore as a European nephrologist from South-Eastern Europe, I could suggest to my African colleagues the follows:

  1. Establishing a useful registry for all sub-Saharan countries including ESRD prevalent and incident patients.
  2. Performing the screening for CKD patients using the abbreviated MDRD equation for GFR and establishing a pan-African CKD registry to facilitate risk analysis and special groups of patients under the risk of developing CKD in the future. Adapting existing clinical practice guidelines for CKD detection and management to address specific problems in every region. [7]
  3. Working closely with other international professional organizations to develop permanent education and multicentre scientific projects in different and specifics aspects of CKD.
  4. Projecting the number of patients of ESRD using of any model for predicting the prevalence and incidence after 10 years. [8]
  5. Working hardly to promote a renal replacement therapy everywhere is needed.
  6. Introducing living expanded criteria renal transplantation using the worldwide experience and working on developing deceased donor donation as a long acting process to avoid organ trafficking.


Therefore, instead of any conclusion, it is time for hard work for any of us, gentlemen!

 
   References Top

1.Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006;10:997-9.  Back to cited text no. 1
    
2.Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol 2010;74 (Supply 1):S13-6.  Back to cited text no. 2
    
3.Bamgloye EL. End-Stage Renal Disease in Sub-Saharan Africa. Ethn Dis 2006;16 (2 Suppl 2):S2-5-9.  Back to cited text no. 3
    
4.Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006;332:563-4.  Back to cited text no. 4
    
5.Correa-Rotter R, Cusumano AM. Present, Prevention, and Management of Chronic Kidney Disease in Latin America. Blood Purif 2008;26:90-4.  Back to cited text no. 5
    
6.Stel VS, Kramer A, Zoccali C, Jager KJ. The 2007 ERA-EDTA Registry Annual Report-a Précis. NDT Plus 2009;2:514-21.  Back to cited text no. 6
    
7.Tsukamoto Y, Jha V, Becker G, Chen HC, Perkovic V, Prodjosudjadi W, et al. A challenge to chronic kidney disease in Asia: The report of the second Asian Forum of Chronic Kidney Disease Initiative. Nephrology (Carlton) 2010;15:248-52.  Back to cited text no. 7
    
8.Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005;16:3736-41.  Back to cited text no. 8
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed1412    
    Printed74    
    Emailed1    
    PDF Downloaded8    
    Comments [Add]    

Recommend this journal